Novocure
Wilco G. is an accomplished financial executive with over a decade of experience as Chief Financial Officer at Novocure Inc. since January 2012. Prior to this role, Wilco G. served as Executive Vice President and CFO at Cephalon Inc. from August 2007 to December 2011 and held the position of Chief Financial Officer at Philips Electronics North America Corporation from August 2002 to August 2007. This extensive background demonstrates a strong expertise in financial leadership and management within the healthcare and electronics sectors.
This person is not in any offices
Novocure
3 followers
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma.